Long COVID in cancer patients: preponderance of symptoms in majority of patients over long time period.
Hiba DagherAnne-Marie ChaftariIshwaria M SubbiahAlexandre E MalekYing JiangPeter LamieBruno GranwehrTeny JohnEduardo YepezJovan BorjanCielito C Reyes-GibbyMary FloresFareed KhawajaMala PandeNoman AliRaniv RojoDaniel D KarpPatrick ChaftariRay HachemIssam I RaadPublished in: eLife (2023)
Funding: This research is supported by the National Institutes of Health/National Cancer Institute under award number P30CA016672, which supports the MD Anderson Cancer Center Clinical Trials Office. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Keyphrases
- clinical trial
- end stage renal disease
- coronavirus disease
- newly diagnosed
- sars cov
- public health
- healthcare
- chronic kidney disease
- peritoneal dialysis
- papillary thyroid
- randomized controlled trial
- electronic health record
- squamous cell
- molecular dynamics
- machine learning
- quality improvement
- decision making
- sleep quality
- young adults
- artificial intelligence
- study protocol
- human health